Benchling is hosting a webinar exploring how reaction data can be structured and searchable from the start to improve reaction planning, reporting, and AI foundations.
Published
Signal category
Presence & Recognition
Quote
“Tomorrow, join Benchling’s Pamela Nasr, PhD and Zachary Reinert, Ph.D. to explore what changes when reaction data is structured and searchable from the start”
— Benchling team
Company
- Industry
- Software Development
- Location
- San Francisco, US
- Company size
- 810 employees
We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific data and AI are built into how science gets done. Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.